Question 1

Does Fédération des caisses Desjardins du Québec own XLO stock?

Accepted Answer

No. Fédération des caisses Desjardins du Québec exited its XLO (Xilio Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 3,300 shares worth $2,782.

Question 2

How many shares of XLO does Fédération des caisses Desjardins du Québec own?

Accepted Answer

None since Q4 2025, when Fédération des caisses Desjardins du Québec exited the position. Its Q3 2025 13F listed 3,300 shares worth $2,782.

Question 3

What is Fédération des caisses Desjardins du Québec's XLO position worth?

Accepted Answer

Fédération des caisses Desjardins du Québec's XLO position was worth $2,782 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Fédération des caisses Desjardins du Québec buying or selling XLO?

Accepted Answer

In Q4 2025, Fédération des caisses Desjardins du Québec exited its entire XLO position.

Question 5

When did Fédération des caisses Desjardins du Québec first buy XLO?

Accepted Answer

Fédération des caisses Desjardins du Québec first reported XLO in its Q4 2024 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$8.96	0
2025-Q3	Unchanged	3,300	0.0%	$2,782	0.0%	$11.80	0
2025-Q2	Unchanged	3,300	0.0%	$2,244	0.0%	$9.52	0
2025-Q1	Unchanged	3,300	0.0%	$2,389	0.0%	$10.14	0
2024-Q4	New	3,300	—	$3,152	0.0%	$13.37	20